Capsinoid Biosynthesis Using Capsiate Synthase and Acyltransferase
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The high cost and low yield of capsinoids, such as capsiate, extracted from sweet peppers make them expensive and difficult to produce in significant amounts, limiting their availability for dietary supplements and metabolic benefits.
Innovation Solution
A method involving the expression of capsiate synthase (CS) and acyltransferase (ACS) in cellular systems like E. coli, using specific substrates like 8-methyl-6-nonenoyl-CoA and vanillyl alcohol, to biosynthetically produce capsinoids, including capsiate, dihydrocapsiate, and nordihydrocapsiate, with subsequent purification to high purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If capsinoids are extracted from sweet peppers, then capsinoids can be obtained, but the cost is high and the yield is low
Solution Approach 1:
The patent uses heterologous expression of capsiate synthase and acyltransferase enzymes in microbial host cells as an intermediary system to produce capsinoids. Instead of directly extracting from sweet peppers, the enzymes are expressed in E. coli or other microbial hosts, which then catalyze the synthesis of capsinoids from provided substrates (vanillyl alcohol and fatty acid derivatives). This intermediary biological system enables scalable production with higher yields and lower costs compared to direct plant extraction.
Solution Approach 2:
The patent employs self-service by utilizing the endogenous metabolic pathways of host cells to provide cofactors, energy, and basic metabolic intermediates required for capsinoid synthesis. The expressed enzymes leverage the host cell's existing biochemical machinery, reducing the need for external supplementation of reaction components and simplifying the overall production process.
2Quantity of substance
If capsinoids are extracted from sweet peppers, then capsinoids can be obtained, but the production amount is limited
Solution Approach 1:
The patent uses heterologous expression of capsiate synthase and acyltransferase enzymes in microbial host cells as an intermediary system to produce capsinoids. Instead of directly extracting from sweet peppers, the enzymes are expressed in E. coli or other microbial hosts, which then catalyze the synthesis of capsinoids from provided substrates (vanillyl alcohol and fatty acid derivatives). This intermediary biological system enables scalable production with higher yields and lower costs compared to direct plant extraction.
Solution Approach 2:
The patent employs universal enzyme systems that can produce multiple capsinoid variants (capsiate, dihydrocapsiate, nordihydrocapsiate) using the same core enzymatic machinery. By varying the fatty acid substrate provided to the acyltransferase, different capsinoid products can be generated from the same expression system, enabling flexible and scalable production of various capsinoid compounds.
3Reliability
If capsaicin is used to activate TRPV1 receptors, then metabolic effects are achieved, but strong pungency and neurotoxicity occur
Solution Approach 1:
The patent applies local quality by modifying the molecular structure at specific positions to alter tissue-specific effects. Capsinoids retain the aromatic vanillyl portion that binds to TRPV1 receptors in the stomach to trigger metabolic effects, while the ester-linked fatty acid portion is modified to prevent activation of oral TRPV1 receptors. This localized structural modification enables selective activation in target tissues (stomach) while avoiding harmful effects in non-target tissues (oral cavity).
Solution Approach 2:
The patent employs parameter changes by altering the chemical structure parameters of capsaicinoids - specifically replacing the amide bond with an ester bond and modifying the fatty acid chain length and saturation. These parameter changes result in compounds (capsinoids) that maintain TRPV1 activation capability in the stomach while significantly reducing pungency and neurotoxicity, as evidenced by their ability to be taken in large amounts without pain.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method allows for the cost-effective and scalable production of capsinoids, overcoming the limitations of natural extraction and providing a sustainable source for metabolic and health benefits.
Implementation Method 1
expressing a capsiate synthase (CS) and an acyltransferase (ACS) in a cellular system; adding 8-methyl-6-nonenoyl-CoA and vanillyl alcohol to the cellular system; and incubating the cellular system for a sufficient time to produce the capsinoid
Data Source
AI summary
Provided herein are methods of making capsinoids including providing a capsiate synthase in a mixture or cellular system, feeding 8-methyl-6-nonenoyl-CoA, 6E-8-methylnonenoic acid or 8-methylnonanoic acid into the mixture or cellular system, feeding vanillyl alcohol into the mixture or cellular system, and collecting capsinoids from the mixture or cellular system.